Head-to-head dispatch
HealthRX vs LillyDirect Foundayo
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A LegitScript-certified telehealth desk with a rare oral GLP tablet route alongside injectables and physician-reviewed intake.
Marked down on: Compounded medications are not FDA-approved
Desk Score
Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.
Marked down on: Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
HealthRX takes this head-to-head with the higher Desk Score, 86/100 (B) against 82/100 (B−) for LillyDirect Foundayo. LillyDirect Foundayo still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
HealthRX
86/100
B
LillyDirect Foundayo
82/100
B−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | HealthRX | LillyDirect Foundayo |
|---|---|---|
| Semaglutide | $190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188) | Not disclosed |
| Tirzepatide | $239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148) | Not disclosed |
| Coverage | United States | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Patients who want a certified, physician-supervised program and the option of an oral tablet instead of an injection. | Patients with commercial insurance who want the cheapest legal brand-name GLP-1. |
| Desk Score | 86/100B | 82/100B− |
The verdict
Desk pick — HealthRXHealthRX takes this head-to-head with the higher Desk Score, 86/100 (B) against 82/100 (B−) for LillyDirect Foundayo. LillyDirect Foundayo still holds its ground where its strengths line up with yours.
Choose HealthRX if…
Patients who want a certified, physician-supervised program and the option of an oral tablet instead of an injection.
$190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188) sema · $239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148) tirz · United States
Choose LillyDirect Foundayo if…
Patients with commercial insurance who want the cheapest legal brand-name GLP-1.
Not disclosed sema · Not disclosed tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: HealthRX · LillyDirect Foundayo.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- HealthRX vs CoreAge Rx
- LillyDirect Foundayo vs Vaylen
- HealthRX vs Strut Health
- LillyDirect Foundayo vs Ondra Health
- HealthRX vs Invigor Medical
- LillyDirect Foundayo vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.